Dose and Dose Intensity as Determinants of Outcome in the Adjuvant Treatment of Breast Cancer

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Regression Models and Life-Tables

1992 • 27,454 citations

Regression Models and Life-Tables

1972 • 27,145 citations

Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease

1959 • 14,850 citations

Asymptotically Efficient Rank Invariant Test Procedures

1972 • 3,392 citations

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy

1992 • 2,084 citations

c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer

1994 • 981 citations

Systemic Treatment of Early Breast Cancer by Hormonal, Cytotoxic, or Immune Therapy:133 Randomised Trials involoving 31 000 Recurrences and 24 000 Deaths Among 75 000 Women (Summary)

1993 • 967 citations

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

1992 • 855 citations

Dose: A critical factor in cancer chemotherapy

1980 • 851 citations

Annual hazard rates of recurrence for breast cancer after primary therapy.

1996 • 833 citations

Pathologic findings from the national surgical adjuvant breast project (protocol 6) I. Intraductal carcinoma (DCIS)

1986 • 829 citations

Dose-Response Effect of Adjuvant Chemotherapy in Breast Cancer

1981 • 765 citations

Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer

1995 • 711 citations

Probability and Statistics.

1978 • 655 citations

PROBABILITY AND STATISTICS

1985 • 581 citations

Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma

1994 • 555 citations

Ovarian ablation in early breast cancer: overview of the randomised trials

1996 • 551 citations

Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer.

1986 • 454 citations

Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer

1985 • 291 citations

Pathologic findings from the national surgical adjuvant breast project protocol B-06 10-year pathologic and clinical prognostic discriminants

1993 • 285 citations

Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541.

1996 • 180 citations

Alkylating agent resistance: in vitro studies with human cell lines.

1985 • 137 citations

1-Phenylalanine mustard (L-PAM) in the management of premenopausal patients with primary breast cancer.Lack of association of disease-free survival with depression of ovarian function

1979 • 127 citations

Evolving concepts in the systemic adjuvant treatment of breast cancer.

1992 • 112 citations

The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up

1994 • 65 citations

A comparison of all-subset Cox and accelerated failure time models with Cox step-wise regression for node-positive breast cancer

1992 • 32 citations

A Feasibility Study of Intensive CAF as Outpatient Adjuvant Therapy for Stage II Breast Cancer in a Cooperative Group: CALGB 8443

1990 • 9 citations

A suggested follow-up time for breast cancer patients

1986 • 5 citations

Endocrine Factors in the Outcome of Systemic Adjuvant Therapy of Early Breast Cancer^a

1993 • 3 citations

Heterogeneity of cancer cells

1993 • 1 citations